IGF1 and posterior cortical atrophy: In PCa, FMT has been proposed as a therapeutic approach aimed at enhancing beneficial bacteria, reducing pathogenic species, and introducing advantageous metabolites such as SCFAs, IGF-1, and folic acid [74].